Using surgical diathermy to make skin incision for Bacterial Infections

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Bacterial Infections+2 More
Using surgical diathermy to make skin incision - Procedure
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial examines if using electrocautery to make skin incisions during shoulder arthroplasty will result in decreased C acnes contamination.

Eligible Conditions
  • Bacterial Infections

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 weeks following surgery

2 weeks following surgery
Proportions of positive C acnes cultures

Trial Safety

Trial Design

2 Treatment Groups

Scalpel incision group
1 of 2
Electrocautery incision group
1 of 2

Active Control

Experimental Treatment

64 Total Participants · 2 Treatment Groups

Primary Treatment: Using surgical diathermy to make skin incision · No Placebo Group · N/A

Electrocautery incision group
Procedure
Experimental Group · 1 Intervention: Using surgical diathermy to make skin incision · Intervention Types: Procedure
Scalpel incision group
Procedure
ActiveComparator Group · 1 Intervention: Using scalpel blade to make skin incision · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 weeks following surgery

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
327 Previous Clinical Trials
601,062 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Male Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: November 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References